Lobbying Relationship

Client

PLASMA PROTEIN THERAPEUTICS ASSOCIATION

More records

Lobbying firm

Plasma Protein Therapeutics Association

More records

  • Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. CMS programs relating to reference pricing systems. Issues relating to Source plasma donation and plasma protein products. The Inflation Reduction Act and provisions relating to plasma derived therapies and drug pricing including Part D rebates and HR 6465, The PLASMA Act.
  • Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them, and the need for continued Source plasma donations. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and HR 3808. CMS programs relating to reference pricing systems. Inflation Reduction Act and negotiation provisions for plasma derived therapies.
  • Issues related to the continuation or change of the Orphan Drug Tax Credit.

Duration: to

General Issues: Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Pharmacy

Spending: about $7,614,024 (But it's complicated. Here's why.)

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Homeland Security - Dept of (DHS), Commerce - Dept of (DOC), State - Dept of (DOS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS),, Internal Revenue Service (IRS), Internal Revenue Service (IRS),, Health & Human Services - Dept of (HHS), Government Accountability Office (GAO), Defense - Dept of (DOD), Treasury - Dept of

Related Foreign Entities: Grifols S.A. (08174 Sant Cugat del Valles, ESP); contribution to lobbying: $0; ownership 0%; Grifols, S.A. (Barcelona, ESP); contribution to lobbying: $33000; ownership 100%; Octapharma AG (Lachen, SUI); contribution to lobbying: $33000; ownership 100%

Bills mentioned

H.R.1600: Patients' Access to Treatments Act of 2015

Sponsor: David McKinley (R-W.Va.)

H.R.2570: Strengthening Medicare Advantage through Innovation and Transparency for...

Sponsor: Diane Black (R-Tenn.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.275: To establish a commission to identify and examine issues of national...

Sponsor: Bobby L. Rush (D-Ill.)

S.275: Medicare Home Infusion Site of Care Act of 2015

Sponsor: Johnny Isakson (R-Ga.)

H.R.34: 21st Century Cures Act

Sponsor: Suzanne Bonamici (D-Ore.)

S.275: Agricultural Export Expansion Act of 2017

Sponsor: Heidi Heitkamp (D-N.D.)

H.R.34: Safe Students Act

Sponsor: Thomas Massie (R-Ky.)

H.R.1600: Veterans Back to Work Act of 2017

Sponsor: Ted Poe (R-Texas)

H.R.2570: Mortgage Fairness Act of 2017

Sponsor: Bill Posey (R-Fla.)

H.R.1628: American Health Care Act of 2017

Sponsor: Diane Black (R-Tenn.)

H.R.2999: Patients' Access to Treatments Act of 2017

Sponsor: David McKinley (R-W.Va.)

H.R.3178: Medicare Part B Improvement Act of 2017

Sponsor: Kevin Brady (R-Texas)

S.1738: Medicare Home Infusion Therapy Access Act of 2017

Sponsor: Mark Warner (D-Va.)

H.R.3163: Medicare Part B Home Infusion Services Temporary Transitional Payment Act

Sponsor: Pat Tiberi (R-Ohio)

H.R.3823: Disaster Tax Relief and Airport and Airway Extension Act of 2017

Sponsor: Kevin Brady (R-Texas)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

H.R.4724: Medicare IVIG Access Enhancement Act

Sponsor: George Holding (R-N.C.)

H.R.34: Energy and Water Research Integration Act of 2019

Sponsor: Eddie Bernice Johnson (D-Texas)

H.R.1628: Enewetak Atoll Cleanup Radiation Study Act

Sponsor: Greg Steube (R-Fla.)

H.R.3163: Transportation, Housing and Urban Development, and Related Agencies...

Sponsor: David E. Price (D-N.C.)

H.R.4724: Students Not Profits Act of 2019

Sponsor: Pramila Jayapal (D-Wash.)

H.R.2905: Medicare IVIG Access Enhancement Act

Sponsor: Earl Blumenauer (D-Ore.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.7839: Continuing Access to In-Home IVIG Act

Sponsor: Doris Matsui (D-Calif.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.3808: Medicare IVIG Access Enhancement Act

Sponsor: Earl Blumenauer (D-Ore.)

H.R.2623: Cameron’s Law

Sponsor: Josh Gottheimer (D-N.J.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

H.R.3808: Afghan Allies Protection Act of 2023

Sponsor: Jason Crow (D-Colo.)

H.R.6465: PLASMA Act

Sponsor: Richard Hudson (R-N.C.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
John "Jay" Greissing Legal Fellow and Counsel, Senate Committee on Judiciary
Carrie Fiarman Senior Legislative Assistant, Rep. Shelley Berkley
AMY ENFANTIS Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
Amy Efantis Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
Julie Birkofer n/a
Tom Lilburn n/a
Brenna Raines n/a
Jonathan McKnight n/a
THOMAS LILBURN n/a
KIMBERLY SEROTA n/a
Chase Thomas n/a
CARRIE FIARMAN ZLATOS n/a
Everett Crosland n/a
Carrie Fiarman-Zlatos n/a
Kym Kilbourne n/a
John Greissing n/a
Bill Speir n/a
Kara Flynn n/a
Jon McKnight n/a
John "Jay" McKnight n/a
Timothy Swope n/a
Daniel Seaton n/a
Anita Brikman n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Amendment
Q1 Report
Amendment
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Amendment
Q1 Report
Amendment
Q4 Report
Amendment
Q3 Report
Q2 Report
Registration
Q1 Report
Amendment
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Amendment
Amendment
Amendment
Q2 Report
Amendment
Q1 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page